2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide

C69H96N24O16 — CID 91578792

IUPAC2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide
SMILESCC(C)CC(N)C(=O)NC1[C@@H](O)[C@@H](CO)O[C@H]1n1cnc2c(N)ccnc21.CCCCC(N)C(=O)NC1[C@@H](O)[C@@H](CO)O[C@H]1n1cnc2c(N)ccnc21.Nc1ccnc2c1ncn2[C@@H]1O[C@H](CO)[C@H](O)C1NC(=O)C(N)C1CC1.Nc1ccnc2c1ncn2[C@@H]1O[C@H](CO)[C@H](O)C1NC(=O)C(N)c1ccccc1
InChIInChI=1S/C19H22N6O4.2C17H26N6O4.C16H22N6O4/c20-11-6-7-22-17-14(11)23-9-25(17)19-15(16(27)12(8-26)29-19)24-18(28)13(21)10-4-2-1-3-5-10;1-8(2)5-10(19)16(26)22-13-14(25)11(6-24)27-17(13)23-7-21-12-9(18)3-4-20-15(12)23;1-2-3-4-10(19)16(26)22-13-14(25)11(7-24)27-17(13)23-8-21-12-9(18)5-6-20-15(12)23;17-8-3-4-19-14-11(8)20-6-22(14)16-12(13(24)9(5-23)26-16)21-15(25)10(18)7-1-2-7/h1-7,9,12-13,15-16,19,26-27H,8,21H2,(H2,20,22)(H,24,28);3-4,7-8,10-11,13-14,17,24-25H,5-6,19H2,1-2H3,(H2,18,20)(H,22,26);5-6,8,10-11,13-14,17,24-25H,2-4,7,19H2,1H3,(H2,18,20)(H,22,26);3-4,6-7,9-10,12-13,16,23-24H,1-2,5,18H2,(H2,17,19)(H,21,25)/t12-,13?,15?,16+,19-;2*10?,11-,13?,14+,17-;9-,10?,12?,13+,16-/m1111/s1
InChIKeyHGTRRRKHLQYFMO-SYSGJUBCSA-N
MW1517.68 g/mol
LogP-3.68
Rot. Bonds23

About 2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide

2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide (PubChem CID 91578792) has the molecular formula C69H96N24O16 and a molecular weight of 1517.68 g/mol. Its IUPAC name is 2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide.

Molecular Properties

Compound Name2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide
PubChem CID91578792
Molecular FormulaC69H96N24O16
Molecular Weight1517.68 g/mol
Exact Mass1516.74
IUPAC Name2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide
SMILESCC(C)CC(N)C(=O)NC1[C@@H](O)[C@@H](CO)O[C@H]1n1cnc2c(N)ccnc21.CCCCC(N)C(=O)NC1[C@@H](O)[C@@H](CO)O[C@H]1n1cnc2c(N)ccnc21.Nc1ccnc2c1ncn2[C@@H]1O[C@H](CO)[C@H](O)C1NC(=O)C(N)C1CC1.Nc1ccnc2c1ncn2[C@@H]1O[C@H](CO)[C@H](O)C1NC(=O)C(N)c1ccccc1
InChIInChI=1S/C19H22N6O4.2C17H26N6O4.C16H22N6O4/c20-11-6-7-22-17-14(11)23-9-25(17)19-15(16(27)12(8-26)29-19)24-18(28)13(21)10-4-2-1-3-5-10;1-8(2)5-10(19)16(26)22-13-14(25)11(6-24)27-17(13)23-7-21-12-9(18)3-4-20-15(12)23;1-2-3-4-10(19)16(26)22-13-14(25)11(7-24)27-17(13)23-8-21-12-9(18)5-6-20-15(12)23;17-8-3-4-19-14-11(8)20-6-22(14)16-12(13(24)9(5-23)26-16)21-15(25)10(18)7-1-2-7/h1-7,9,12-13,15-16,19,26-27H,8,21H2,(H2,20,22)(H,24,28);3-4,7-8,10-11,13-14,17,24-25H,5-6,19H2,1-2H3,(H2,18,20)(H,22,26);5-6,8,10-11,13-14,17,24-25H,2-4,7,19H2,1H3,(H2,18,20)(H,22,26);3-4,6-7,9-10,12-13,16,23-24H,1-2,5,18H2,(H2,17,19)(H,21,25)/t12-,13?,15?,16+,19-;2*10?,11-,13?,14+,17-;9-,10?,12?,13+,16-/m1111/s1
InChIKeyHGTRRRKHLQYFMO-SYSGJUBCSA-N
XLogP-3.68
TPSA646.16 Ų
H-Bond Donors20
H-Bond Acceptors36
Rotatable Bonds23
Heavy Atoms109
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001517.68
LogP ≤ 5-3.68
H-Bond Donors ≤ 520
H-Bond Acceptors ≤ 1036

Analyze 2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-Deoxy-1-(6-((2,2-diphenylethyl)amino)-2-(((2-((((1-(2-pyridinyl)-4-piperidinyl)amino)carbonyl)amino)ethyl)amino)carbonyl)-9H-purin-9-yl)-N-ethyl-beta-D-ribofuranuronamide
CID 9833519
N-[2-[[2-[4-[[2-[4-[[9-[(3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]phenyl]acetyl]amino]phenyl]acetyl]amino]ethyl]octadecanamide
CID 46876505
(2S,3S,4R,5R)-N-cyclopropyl-3,4-dihydroxy-5-[6-[2-[1-(pyridin-3-ylmethyl)indol-3-yl]ethylamino]purin-9-yl]oxolane-2-carboxamide
CID 10347628
(2S,3S,4R,5R)-N-cyclopropyl-3,4-dihydroxy-5-[6-[2-[1-(2-pyrrolidin-1-ylethyl)indol-3-yl]ethylamino]purin-9-yl]oxolane-2-carboxamide
CID 10370570
(2S,3S,4R)-N-cyclopropyl-3,4-dihydroxy-5-[6-[2-[1-(2-piperidin-1-ylethyl)indol-3-yl]ethylamino]purin-9-yl]oxolane-2-carboxamide
CID 46876395
(2S,3S,4R)-N-cyclopropyl-5-[6-[2-[1-[[2-(dimethylamino)phenyl]methyl]indol-3-yl]ethylamino]purin-9-yl]-3,4-dihydroxyoxolane-2-carboxamide
CID 46876476
6-(2,2-diphenylethylamino)-9-((2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxytetrahydrofuran-2-yl)-N-(2-(3-(pyridin-2-ylmethyl)ureido)ethyl)-9H-purine-2-carboxamide
CID 46886597
(2S)-2-amino-N-[[3-[3-[[[(2S)-2-amino-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]butanoyl]amino]methyl]phenyl]phenyl]methyl]-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]butanamide
CID 57393722
(2S)-2-amino-N-[[3-[[[(2S)-2-amino-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]butanoyl]amino]methyl]phenyl]methyl]-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]butanamide
CID 57393723
(2S)-2-amino-N-[[4-[[[(2S)-2-amino-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]butanoyl]amino]methyl]phenyl]methyl]-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]butanamide
CID 57400687
(2S)-2-amino-N-[[2-[2-[[[(2S)-2-amino-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]butanoyl]amino]methyl]phenyl]phenyl]methyl]-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]butanamide
CID 57402463
9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(2,2-diphenylethylamino)-N-[2-[(1-pyridin-2-ylpiperidin-4-yl)carbamoylamino]ethyl]purine-2-carboxamide
CID 90655901

Frequently Asked Questions

What is the IUPAC name of 2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide?
The IUPAC name of 2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide (CID 91578792) is 2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide.
What is the SMILES notation for 2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide?
The canonical SMILES for 2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide is CC(C)CC(N)C(=O)NC1[C@@H](O)[C@@H](CO)O[C@H]1n1cnc2c(N)ccnc21.CCCCC(N)C(=O)NC1[C@@H](O)[C@@H](CO)O[C@H]1n1cnc2c(N)ccnc21.Nc1ccnc2c1ncn2[C@@H]1O[C@H](CO)[C@H](O)C1NC(=O)C(N)C1CC1.Nc1ccnc2c1ncn2[C@@H]1O[C@H](CO)[C@H](O)C1NC(=O)C(N)c1ccccc1.
What is the InChIKey of 2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide?
The InChIKey is HGTRRRKHLQYFMO-SYSGJUBCSA-N. The full InChI is InChI=1S/C19H22N6O4.2C17H26N6O4.C16H22N6O4/c20-11-6-7-22-17-14(11)23-9-25(17)19-15(16(27)12(8-26)29-19)24-18(28)13(21)10-4-2-1-3-5-10;1-8(2)5-10(19)16(26)22-13-14(25)11(6-24)27-17(13)23-7-21-12-9(18)3-4-20-15(12)23;1-2-3-4-10(19)16(26)22-13-14(25)11(7-24)27-17(13)23-8-21-12-9(18)5-6-20-15(12)23;17-8-3-4-19-14-11(8)20-6-22(14)16-12(13(24)9(5-23)26-16)21-15(25)10(18)7-1-2-7/h1-7,9,12-13,15-16,19,26-27H,8,21H2,(H2,20,22)(H,24,28);3-4,7-8,10-11,13-14,17,24-25H,5-6,19H2,1-2H3,(H2,18,20)(H,22,26);5-6,8,10-11,13-14,17,24-25H,2-4,7,19H2,1H3,(H2,18,20)(H,22,26);3-4,6-7,9-10,12-13,16,23-24H,1-2,5,18H2,(H2,17,19)(H,21,25)/t12-,13?,15?,16+,19-;2*10?,11-,13?,14+,17-;9-,10?,12?,13+,16-/m1111/s1.
What are the key properties of 2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide?
2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide has a molecular weight of 1517.68 g/mol, XLogP of -3.68, 23 rotatable bonds, 20 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-cyclopropylacetamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]hexanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-4-methylpentanamide;2-amino-N-[(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-2-phenylacetamide is sourced from PubChem (CID 91578792), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).